Pathogenic Steam Launch Draws 2,300 Reviews, 100,000 Sales in Week
The strong early sales and positive reception signal a successful launch for a niche indie title, with the game's unique body-themed setting and build variety resonating with players.
Reporting from 1 source: Denfaminicogamer.
Pathogenic, a 2D rogue-like shooter from Aberrant Labs and Slug Disco, launched on Steam on July 16. Within two weeks it earned over 2,300 reviews, 93% positive, a "Very Positive" rating, and surpassed 100,000 sales in its first week. Peak concurrent players exceeded 5,800. Players control a pathogen navigating a randomly generated human body, fighting immune cells and rival parasites.
The game puts the player in control of a single pathogen inside a human body, facing immune cells and rival parasites across organs like the epidermis, intestines, and liver. Builds revolve around organelles placed in external and internal slots, with mitochondria and infusers altering performance. Seven unlockable pathogens, including bacteria and amoeba, add variety. A free demo is available, and the game supports Japanese.
Synthesized by Yomimono from the 1 cited source below, including Japanese-language reporting where cited, then editorially reviewed before publishing.